Page 213 - Read Online

Conclusion the TNM Classifi cation of malignant tumours. J Thorac Oncol
2007;2:706-14.
This single center analysis suggests that at least at 13. Gironés R, Torregrosa D, Gómez-Codina J, Maestu I,
our region, lung cancer remains a men disease and Tenias JM, Rosell R. Lung cancer chemotherapy decisions in
tobacco-related cancer. Advances and improvements older patients: the role of patient preference and interactions
on OS seemed to have been achieved only in those with physicians. Clin Transl Oncol 2012;14:183-9.
tumors unrelated to smoking (non-smoker women EGFR 14. Gironés R, Torregrosa D, Gómez-Codina J, Maestu I,
mutated patients). Efforts to reduce tobacco use and carry Tenias JM, Rosell R. Prognostic impact of comorbidity in
elderly lung cancer patients: use and comparison of two
on with improvement in treatment could modify this scores. Lung Cancer 2011;72:108-13.
disappointing survival for our patients. 15. Gironés R, Torregrosa D, Díaz-Beveridge R. Comorbidity
Financial support and sponsorship disability and geriatric syndromes in elderly breast cancer
survivors. Results of a single-center experience. Crit Rev
Nil. Oncol Hematol 2010;73:236-45.
16. Gironés R, Torregrosa D, Maestu I, Gómez-Codina J,
Confl icts of interest Tenias JM, Costa RR. Comprehensive Geriatric
There are no confl icts of interest. Assessment (CGA) of elderly lung cancer patients:
a single-center experience. J Geriatr Oncol 2012;3:98-103.
References 17. Santos-Martínez MJ, Curull V, Blanco ML, Macià F, Mojal S,
Vila J, Broquetas JM. Lung cancer at a university hospital:
1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, epidemiological and histological characteristics of a recent and
Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence historical series. Arch Bronconeumol 2005;41:307-12.
and mortality worldwide: sources, methods and major patterns 18. Sánchez de Cos Escuín J, Miravet Sorribes L, Abal Arca J,
in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86. Núñez Ares A, Hernández Hernández J, Castañar Jover AM,
2. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Muñoz Gutiérrez FJ, García Arangüena L, Alonso MA,
Wingo PA, Jemal A, Ward E, Anderson RN, Edwards BK. Montero Martínez MC, Allende González J, Sánchez
Annual report to the nation on the status of cancer, 1975-2000, Hernández I. The EpicliCP-2003 study: a multicenter
featuring the uses of surveillance data for cancer prevention epidemiological and clinical study of lung cancer in Spain.
and control. J Natl Cancer Inst 2003;95:1276-99. Arch Bronconeumol 2006;42:446-52.
3. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, 19. Miravet L, Peláez S, Paradís A, Arnal M, Cabadés F.
Barnett MJ, Hsieh LJ, Begg CB. Variations in lung cancer risk Epidemiological study of lung cancer in the northern part of the
among smokers. J Natl Cancer Inst 2003;95:470-8. province of Castellón. Arch Bronconeumol 2001;37:298-301.
4. Janssen-Heijnen ML, Coebergh JW. The changing 20. Hernández IS, Alonso JL, Sánchez CA. Epidemiology of lung
epidemiology of lung cancer in Europe. Lung Cancer cancer in Spain and forecast for the future. Arch Bronconeumol
2003;41:245-58. 2006;42:594-9.
5. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung 21. National Cancer Institute. Non-Small Cell Lung Cancer
cancer: looking to the future. J Clin Oncol 2005;23:3175-85. Treatment (PDQ®): General Information About Non-Small
6. Thomas L, Doyle LA, Edelman MJ. Lung cancer in women: Cell Lung Cancer (NSCLC). Available from: http://www.
emerging differences in epidemiology, biology and therapy. cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/
Chest 2005;128:370-81. healthprofessional. [Last accessed on 2011 Nov 07].
7. Sánchez de Cos Escuín J, Disdier Vicente C, Corral Peñafi el J, 22. American Cancer Society. Cancer Facts and Figures. Atlanta:
Riesco Miranda JA, Sojo González MA, Masa Jiménez JF. American Cancer Society; 2013.
Overall long-term survival in lung cancer analyzed in 610 23. Salmerón D, Chirlaque MD, Isabel Izarzugaza M,
unselected patients. Arch Bronconeumol 2004;40:268-74. Sánchez MJ, Marcos-Gragera R, Ardanaz E, Galceran J,
8. Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. Mateos A, Navarro C. Lung cancer prognosis in Spain: the
Pathology and Genetics of Tumours of the Lung, Pleura, role of histology, age and sex. Respir Med 2012;106:1301-8.
Thymus and Heart. Lyon: IARC Press; 2004. 24. Navarro C, Martos C, Ardanaz E, Galceran J, Izarzugaza I,
9. Cadioli A, Rossi G, Costantini M, Cavazza A, Migaldi M, Peris-Bonet R, Martínez C; Spanish Cancer Registries
Colby TV. Lung cancer histologic and immunohistochemical Working Group. Population-based cancer registries in Spain
heterogeneity in the era of molecular therapies: analysis of 172 and their role in cancer control. Ann Oncol 2010;21:iii3-13.
consecutive surgically resected, entirely sampled pulmonary 25. Montero C, Rosales M, Otero I, Blanco M, Rodríguez G,
carcinomas. Am J Surg Pathol 2014;38:502-9. Peterga S, Pita S, Verea H. Lung cancer in the health care area
10. Choy B, Findeis-Hosey JJ, Li F, McMahon LA, Yang Q, of A Coruña (Spain): incidence, clinical approach and survival.
Xu H. High frequency of coexpression of maspin with p63 and Arch Bronconeumol 2003;39:209-16.
p53 in squamous cell carcinoma but not in adenocarcinoma of 26. Alonso-Fernández MA, García-Clemente M, Escudero-Bueno C;
the lung. Int J Clin Exp Pathol 2013;6:2542-7. Grupo ASTURPAR (Sociedad Asturiana de Patología del Aparato
11. Montezuma D, Azevedo R, Lopes P, Vieira R, Cunha AL, Respiratorio) del Cáncer del Pulmón (GACP). Characteristics of
Henrique R. A panel of four immunohistochemical lung cancer in a region in northern Spain. Arch Bronconeumol
markers (CK7, CK20, TTF-1 and p63) allows accurate 2005;41:478-83.
diagnosis of primary and metastatic lung carcinoma on biopsy 27. Hernández-Hernández JR, Heras-Gómez F, Cordovilla-Pérez MR,
specimens. Virchows Arch 2013;463:749-54. Antolín-García T, Bollo De Miguel E; Grupo de Estudio
12. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, CB07-SOCALPAR. Incidence of bronchopulmonary cancer
Rami-Porta R, Postmus PE, Rusch V, Sobin L . The IASLC in Castilla y Leon and Cantabria in the year 2007. A study
Lung Cancer Staging Project: proposals for the revision of the by the Castilla y Leon and Cantabria Respiratory Diseases
TNM stage groupings in the forthcoming (seventh) edition of Society (SOCALPAR). Arch Bronconeumol 2010;46:7-14.

206 Journal of Cancer Metastasis and Treatment ¦ Volume 1 ¦ Issue 3 ¦ October 15, 2015 ¦